Clinical implications of SOCS1 methylation in myelodysplastic syndrome-Reference-Cited by-同舟云学术

Clinical implications of SOCS1 methylation in myelodysplastic syndrome

Published:2006-11 Issue:3 Volume:135 Page:317-323
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Wu Shang-Ju,Yao Ming,Chou Wen-Chien,Tang Jih-Luh,Chen Chien-Yuan,Ko Bo-Sheng,Huang Shen-Yi,Tsay Woei,Chen Yao-Chang,Shen Ming-Ching,Wang Chiu-Hwa,Yeh Yo-Chia,Tien Hwei-Fang

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2006.06293.x/fullpdf

Reference44 articles.

1. Aberrant p15 gene promoter methylation in therapy-related myelodysplastic syndrome and acute myeloid leukaemia: clinicopathological and karyotypic associations

2. Proposals for the classification of the myelodysplastic syndromes

3. Hypermethylation of the suppressor of cytokine signalling-1 (SOCS-1) in myelodysplastic syndrome

4. SOCS1 methylation in patients with newly diagnosed acute myeloid leukemia

5. Acquisition of JAK2, PTPN11, and RAS mutations during disease progression in primary myelodysplastic syndrome

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genome-wide methylation sequencing identifies progression-related epigenetic drivers in myelodysplastic syndromes;Cell Death & Disease;2020-11

2. Identification and validation of prognosis‐related DLX5 methylation as an epigenetic driver in myeloid neoplasms;Clinical and Translational Medicine;2020-06

3. Realgar (α-As4S4) Treats Myelodysplasic Syndromes through Reducing DNA Hypermethylation;Chinese Journal of Integrative Medicine;2020-05-16

4. High methylation of the 4-aminobutyrate aminotransferase gene predicts a poor prognosis in patients with myelodysplastic syndrome;International Journal of Oncology;2018-12-04

5. Epigenetic Changes of the Immune System with Role in Tumor Development;Methods in Molecular Biology;2018